On November 16, Aehr Test fell 5.28% Overnight, trading at $53.97/share, with turnover of $0.5318 million.
The move followed continued cooling in the market’s post-earnings trading momentum after investors had previously bid up the stock on stronger-than-expected quarterly results, a higher full-year revenue outlook, and progress in AI chip testing orders and deployments.
Previously disclosed results showed first-quarter revenue of $33.007 million versus $27.072 million expected, adjusted EPS of $0.28 versus $0.11 expected, and backlog of $100.9 million as of September 25. Management also raised full-year revenue guidance to $150 million and highlighted deployment progress with a major AI accelerator customer, including a fully configured FOX-XP wafer-level burn-in system planned for installation at a partner facility in Taiwan in early 2027.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments